U.S. District Court For District Of Delaware Denied The Motion For Preliminary Injunction Filed By United Therapeutics That Sought To Block Launch Of Liquidia's Yutrepia (Treprostinil) Inhalation Powder For PH-ILD

Benzinga · 06/03 11:18

The ruling reinforces the clear path for the U.S. Food and Drug Administration to issue a final decision on the amended New Drug Application (NDA) for YUTREPIA.